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Summ a r y
Premature ovarian failure is a major cause of female infertility. The genetic causes 
of this disorder remain unknown in most patients. Using whole-exome sequence 
analysis of a large consanguineous family with inherited premature ovarian failure, 
we identified a homozygous 1-bp deletion inducing a frameshift mutation in STAG3 
on chromosome 7. STAG3 encodes a meiosis-specific subunit of the cohesin ring, 
which ensures correct sister chromatid cohesion. Female mice devoid of Stag3 are 
sterile, and their fetal oocytes are arrested at early prophase I, leading to oocyte 
depletion at 1 week of age.
Premature ovarian failure, the end point of primary ovarian  insufficiency, affects approximately 1% of women worldwide. Patients with pre-mature ovarian failure present with at least a 6-month history of amenorrhea 
and elevated plasma levels of follicle-stimulating hormone (>40 mIU per milliliter). 
The disorder can result from premature depletion of the follicle pool, follicular 
atresia, follicle growth arrest, or ovarian dysgenesis. Although a majority of cases 
are idiopathic, premature ovarian failure can be caused by infectious agents, che-
motherapy, pelvic surgery, autoimmune disease, environmental factors, or genetic 
conditions.1 The disorder is observed in syndromic diseases — for example, Turner’s 
syndrome and BPES (blepharophimosis, ptosis, and epicanthus inversus syndrome) 
— or in isolated disease.
In at least 10 to 15% of patients with premature ovarian failure, a genetic cause 
has been determined.2,3 To date, genetic alterations including chromosomal dele-
tions, rearrangements, and autosomal and X-linked mutations have been identified 
in patients with this disorder.2,4,5 Genomewide association studies have also pro-
vided insight into novel genomic regions that are important in ovarian insuffi-
ciency and failure.6,7 However, in most cases of premature ovarian failure, no ge-
netic cause has been identified.2,3,4,6
In analyses of samples obtained from a consanguineous Palestinian family with 
premature ovarian failure, we previously identified a 10-Mb region on 7q21.3–22.2 
and a 3-Mb region on 7p21.1–15.3 that had significant linkage with premature 
ovarian failure (maximum logarithm of the odds [LOD] score, 3.26), which was 
consistent with homozygosity by descent.8 By combining linkage data and exome 
sequencing in this family, we have identified a homozygous 1-bp deletion in the 
gene encoding stromal antigen 3 (STAG3), a finding that is further supported by 
the phenotype of female mice with a homozygous disruption in Stag3.
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C a se R eport
The Middle Eastern Family 1 (MO1DA), whose 
members have been described in detail previously,8 
presented at the Department of Genetics at Ha-
dassah Hospital in Jerusalem for treatment of pre-
mature ovarian failure, the extreme end of the 
spectrum of primary ovarian insufficiency (Fig. 1A). 
The proband (Family Member IV-1) was the eldest 
of six sisters. The family history showed that in 
this consanguineous Middle Eastern family of 
Palestinian origin, five women presented with 
premature ovarian failure. Of the six sisters in 
generation IV, four were affected. The mother 
(Family Member III-1) and father (Family Member 
III-2) were first cousins and were linked by at 
least three other previous consanguineous mar-
riages. In addition to the four sisters in genera-
tion IV, premature ovarian failure had also been 
diagnosed in a maternal aunt. The nonaffected 
sisters of the proband (Family Members IV-3 and 
IV-4) had menarche at ages within the normal 
range and were fertile; they naturally conceived 
two and three children, respectively. The two 
brothers (Family Members IV-2 and IV-5) were 
also fertile, with three children each.
All four affected sisters had received the di-
agnosis of premature ovarian failure between 
the ages of 17 and 20 years and initially pre-
sented with primary amenorrhea. On physical 
examination, they all had small and undevel-
oped breasts; the height was within the normal 
range. Ultrasonographic examination showed bi-
lateral streak gonads (i.e., composed mainly of 
fibrous tissue). Hormonal studies that were per-
formed at the time of diagnosis showed the ex-
pected high gonadotropin levels and low estradiol 
levels, with follicle-stimulating hormone levels 
of more than 45 mIU per milliliter (normal 
range, 3 to 21 mIU per milliliter), luteinizing 
hormone levels of more than 18 mIU per milli-
liter (normal range, 1 to 18 mIU per milliliter), 
and estradiol levels of less than 22 pg per milli-
liter (81 pmol per liter; normal range, 30 to 190 pg 
per milliliter [110 to 697 pmol per liter]). We 
ruled out the presence of autoantibodies in all 
four sisters.
We performed genetic testing on samples 
obtained from the four sisters with the disorder 
to rule out known genetic causes of premature 
ovarian failure. The results of this testing showed 
a normal 46,XX karyotype and no premutations 
in the gene encoding fragile X mental retarda-
tion 1 (FMR1). At the age of 19, the youngest 
sister with premature ovarian failure (Family 
Member IV-10) was found to have simultaneous 
bilateral ovarian tumors consisting of a gonado-
blastoma on the right ovary and a complex tu-
mor consisting of a dysgerminoma, embryonal 
carcinoma, and choriocarcinoma in the left 
ovary. No other relevant medical finding was 
identified in the other family members with 
premature ovarian failure.
Me thods
Participants and Genetic Studies
We obtained written informed consent from all 
participants in the study. After whole-exome cap-
ture on Agilent SureSelectXT 50 Mb Exon Capture, 
we performed high-throughput sequencing of the 
DNA obtained from one participant with prema-
ture ovarian failure and from one of her unaf-
fected sisters. We performed Sanger sequencing 
to confirm the segregation of the identified vari-
ants in the unaffected parents, affected sisters, 
and unaffected siblings (Table S2 in the Supple-
mentary Appendix, available with the full text of 
this article at NEJM.org).
Mouse Model
The OVE2312C mouse line, obtained from the 
Jackson Laboratory (Sacramento, CA), was gener-
ated with the use of a lentiposon insertional mu-
tagenesis strategy and carries an insertion in 
Stag3 that leads to a null allele (Fig. S1, S3, and S5 
in the Supplementary Appendix). All experiments 
involving animals were performed in accordance 
with procedures approved by the institutional 
animal ethics committee at the Cancer Research 
Center in Salamanca.
R esult s
Homozygous Mutation in STAG3
We performed whole-exome sequencing of DNA 
obtained from two of the sisters, one who was 
affected with premature ovarian failure (Family 
Member IV-1) and the other who was unaffected 
(Family Member IV-3) (Fig. 1A). Exome sequenc-
ing generated 3.3 billion reads per sample and 
covered 92.6% of the targeted sequence at 10× or 
greater (Table S3 in the Supplementary Appen-
dix). We filtered the single-nucleotide variants 
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and insertions or deletions using the following 
criteria: location in the linkage peaks, homozy-
gosity in the affected sibling, heterozygosity in 
the unaffected sibling, and absence from the 
Single-Nucleotide Polymorphism Database (dbSNP),
build 132, and the Human Gene Mutation Data-
base. Our data confirmed the large homozygous 
regions on chromosome 7 in Family Member 
IV-1 but not in Family Member IV-3. The filtering 
algorithm identified eight variants in six genes, 
all located within the 7q21.3–22.2 linkage peak. 
Of these six genes, five were ruled out as un-
likely to harbor a causal mutation for premature 
ovarian failure on the basis of known function or 
domain of expression (Tables S4 and S5 in the 
Supplementary Appendix).
The remaining gene, STAG3, carried a 1-bp 
deletion, c.968delC. STAG3 encodes a subunit of 
cohesin, a large protein complex that is essential 
for proper pairing and segregation of chromo-
somes during meiosis.9-11 The deletion results 
in a deleterious frameshift p.F187fs*7 mutation 
and a premature stop codon, which predicts 
omission of exons 8 to 34 from translated STAG3
messenger RNA. The resulting transcript would 
either undergo nonsense-mediated decay12 or 
result in a severely truncated protein. In the mu-
tant protein, the STAG domain would be com-
promised by truncation (Fig. 1B) and the arma-
dillo (ARM)-type domain (which is predicted to 
interact with a nucleic acid or another protein) 
would be absent. Human STAG3 expression is 
restricted to early meiosis in fetal ovaries in fe-
males and from the onset of spermatogenesis in 
males.13-15
The STAG3 mutation was confirmed on Sanger 
sequencing, and the mutation cosegregated with 
the phenotype for premature ovarian failure 
(Fig. S2 in the Supplementary Appendix). The 
four sisters with premature ovarian failure were 
homozygous for the STAG3 mutation, whereas 
the unaffected family members who were ana-
lyzed were either heterozygous or homozygous 
for the nonmutant allele (Fig. 1A).
Inactivation of Stag3 in Murine Model
To confirm that the loss of function of STAG3 is 
associated with premature ovarian failure, we 
characterized the female phenotype of mice car-
rying an insertional null mutation in Stag3. 
Hemizygous mice transmitted the mutation to 
their offspring at mendelian frequencies (1:2:1). 
Homozygous mutant mice were identified by 
means of the Southern blot technique (Fig. S3 in 
the Supplementary Appendix). The absence of 
both transcript and protein was shown on North-
ern blot analysis and immunofluorescence, indi-
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Figure 1. Identification of a Mutation in the Coding Sequence of STAG3 
in a Consanguineous Family with Premature Ovarian Failure.
Panel A shows the family pedigree, with double horizontal lines indicating 
consanguineous unions. Squares denote male family members, circles fe-
male family members, diamonds offspring for whom information on sex 
was not available (with the number of children indicated inside the symbols 
if it was known), solid symbols affected family members, open symbols un-
affected family members, and slashes deceased family members. Arrows 
point to the two sisters who provided samples for whole-exome sequencing. 
The genotypes for the mutation in STAG3 are indicated below each family 
member whose DNA was available for Sanger sequencing, as shown with an 
asterisk. Panel B shows the organization of STAG3 (from Ensembl, reference 
transcript ENST00000426455). Exons are depicted as red vertical bars and 
introns as dashed lines. The solid bars indicate coding exons, and the open 
bars at each end indicate noncoding exons. The structure of the nonmutant 
protein is shown below the exons for the longest isoform of 1225 amino acids, 
with coding exons shown as bars with alternating colors. The mutation lies 
in exon 7 (indicated by the arrow), which encodes the first part of the STAG 
domain (in green). The predicted length of the mutant protein (if translated) 
is 194 amino acids, as induced by the frameshift mutation and premature 
stop codon. In the mutant protein, the armadillo (ARM)-type domain, which 
is predicted to interact with a nucleic acid or another protein, would be absent.
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cating that the insertional mutation is a null 
 allele (Fig. S4 and S5 in the Supplementary Ap-
pendix). STAG3 expression is restricted to the 
germline in mice,16 and Stag3−/− mice showed no 
overt phenotype apart from sterility.
In mouse oocytes, the depletion of genes that 
encode subunits of the meiotic cohesin complex 
induces phenotypes ranging from sterility associ-
ated with premature arrest of meiotic prophase I 
at a zygotene-like stage (in Rec8)17 to subfertility 
caused by mild defects in the homologous chromo-
some synapsis at the pachytene stage (in Rad21l).18 
Histologic analysis of whole ovaries of Stag3−/− 
female mice at 1, 2, and 6 weeks of age showed 
a distinctive lack of oocytes and ovarian follicles 
and a dense stroma, indicating a severe and very 
early ovarian dysgenesis (Fig. 2A). Since female 
germ cells enter meiosis during embryogenesis,19 
we analyzed meiotic defects in Stag3−/− fetal oocytes. 
We analyzed oocytes from 15.5 to 19.5 gestational 
days (corresponding to the leptotene to diplotene 
stages of prophase I), using immunofluorescence 
staining of the SYCP3 component of the synapto-
nemal complex on chromosome spreads. Pachy-
tene nuclei, characterized by 20 pairs of synapsed 
homologous chromosomes in control oocytes, were 
not observed in mutant Stag3 oocytes (Fig. 2B). The 
axial elements, the first parts of the synaptone-
mal complex to be assembled, did not progress 
beyond the leptotene stage in the mutant oocytes. 
Instead, they were very short and did not elon-
gate to form the thin SYCP3 threads observed in 
late leptotene and zygotene wild-type oocytes 
(Fig. 2B, and Fig. S5 in the Supplementary Ap-
pendix). Stag3−/− oocytes did not show positive 
staining for SYCP1, a component of the trans-
verse filament of the synaptonemal complex, 
which assembles after axial elements (Fig. 2B). 
We concluded that synapsis between homo-
logues was disrupted at an early leptotene-like 
stage and that this premature arrest did not 
impair the formation of programmed double-
strand breaks or the recruitment of the RAD51 
recombinase on recombination foci, because 
these processes appeared to be similar in nor-
mal and mutant oocytes (Fig. S6 in the Supple-
mentary Appendix).
Because the lack of the two meiosis-specific 
cohesin subunits RAD21L and REC8 leads to 
defective loading of other cohesin subunits and 
defective assembly of axial elements,11 we asked 
whether the loss of STAG3 also compromised the 
loading of other cohesins in fetal oocytes. Im-
munolabeling of the various meiotic cohesin 
subunits and SYCP3 in wild-type and Stag3−/− fetal 
ovaries showed absent or very limited colocaliza-
tion of other cohesins with SYCP3 in the Stag3−/− 
mice (Fig. S7 in the Supplementary Appendix). We 
would therefore suggest that STAG3 forms com-
plexes in vivo with REC8, SMC3, SMC1β, and 
RAD21L, independent of the somatic or meiotic 
kleisin (RAD21), and that STAG3 is essential for 
the formation of a functional cohesin ring and 
synaptonemal complex in mice and humans.
In addition to its role in the formation of a 
synaptonemal complex,11,18 the cohesin complex 
holds sister chromatids together.10,20 Therefore, 
we analyzed centromeric sister chromatid cohe-
sion by means of immunolocalization of centro-
meres in fetal oocytes. Mutant oocytes showed an 
obvious loss of centromeric sister chromatid co-
hesion (Fig. S8 in the Supplementary Appendix). 
These results suggest that STAG3-containing 
cohesin complexes also play a central role in 
the maintenance of sister chromatid cohesion 
in mammalian oocytes (Fig. S9 in the Supple-
mentary Appendix).
Discussion
Using a combination of linkage data and exome 
sequencing, we identified a frameshift mutation 
in STAG3 in a large consanguineous family with 
premature ovarian failure. All affected family 
members who provided samples for analysis 
were homozygous for the mutation. Our results 
are supported by the sterile phenotype and the 
very early ovarian defects observed in Stag3−/− fe-
male mice. The early meiotic arrest and the centro-
meric chromosomal cohesion defects observed 
in Stag3−/− fetal oocytes provide further evidence 
that Stag3 is essential for the assembly of the 
meiotic cohesin ring and the synaptonemal com-
plex. Given the essential role of STAG3 in meiosis, 
we expect that a homozygous defect would lead 
to infertility in both sexes. However, since the 
brothers of the proband are heterozygous, we 
cannot draw conclusions from this family with 
regard to male infertility. Nevertheless, we found 
that male Stag3−/− mice were infertile (Fig. S10 in 
the Supplementary Appendix).
Mutations in mice that affect other meiotic 
cohesin subunits also result in abnormal oocyte 
development. Specifically, oocytes show meiotic 
defects because of abnormal formation of axial 
elements (in mutant REC8),17 impaired sister chro-
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matid cohesion leading to massive aneuploidy 
during the second meiotic division (in mutant 
SMC1β),21 or mild defects in synapsis resulting in 
premature depletion of the oocyte pool (in mutant 
RAD21L).18 Furthermore, the gradual loss of mei-
otic cohesins or their protector, shugoshin-like 2, 
is an important mechanism of meiotic nondis-
junction and age-related aneuploidy and infertility, 
as shown in mice and postulated in humans.22-25
Although some human cases of premature 
ovarian failure have been attributed to defective 
chromosomal cohesion at later stages of meiosis 
because of supernumerary chromosomes,26 our re-
sults show that this disorder can also result from 
a defect in sister chromatid cohesion much earli-
er, in prophase. The very few mutations that have 
been identified in meiotic genes in association 
with human infertility result in azoo spermia or 
recurrent pregnancy loss or alter processes other 
than the formation of the synaptonemal com-
plex.27-30 Genetic analyses of samples obtained 
from four other families with recessive inheri-
tance of infertility ruled out linkage with the 
STAG3 locus, highlighting the genetic heteroge-
neity of this disease and suggesting that its re-
cessive forms are infrequent (see Section I in the 
Supplementary Appendix).
Cohesins are implicated in the repair, replica-
tion, and recombination of DNA, as well as in 
chromosomal stability, transcription regulation, 
stem-cell pluripotency, and cell differentiation.10,20,31 
Our study expands the spectrum of cohesinopa-
thies, which include severe constitutional disorders 
such as the Cornelia de Lange syndrome and the 
Roberts syndrome, to one with isolated infertility.
In addition to having roles in crucial develop-
mental processes, genes such as SMC1, SMC3, 
STAG3, STAG2, and RAD21 are mutated in a variety 
of cancers32,33 (see also the Catalogue of Somatic 
Mutations in Cancer [COSMIC] database). Indeed, 
somatic mutations in RAD21, SMC1A, SMC3, and 
STAG2 (a paralogue of STAG3) are considered to 
be driver mutations in acute myeloid leukemias 
and several solid tumors,34-37 and loss of hetero-
zygosity in STAG3 occurs in epithelial ovarian 
carcinomas.38 It is worth noting that at the age 
of 19, the youngest sister with premature ovari-
an failure (Family Member IV-10) presented with 
bilateral ovarian cancer. The germinal origin of 
these tumors suggests a possible role for the 
germline STAG3 truncating mutation in genomic 
instability in the few oocytes that survived ovar-
ian degeneration. Accordingly, it would be inter-
B
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Figure 2. Premature Ovarian Failure in Stag3−/− Mice.
Panel A shows a comparative histologic analysis of ovarian sections from 
wild-type and Stag3−/− mice at 7 days, 15 days, and 6 weeks of age. Growing 
oocytes and follicle development are evident in wild-type animals at each 
age. Ovaries with no follicles or oocytes were observed in their Stag3-defi-
cient littermates. At 6 weeks, Stag3-deficient mice showed atrophic and fi-
brotic ovaries. The scale bar represents 100 μm in 7-day sections and 200 μm 
in 15-day and 6-week sections. Panel B shows immunostaining assays for 
SYCP3 (detected in red) and SYCP1 (detected in green) in murine fetal oocytes. 
The yellow lines indicate the formation of synapses. SYCP1, a marker for 
transverse filaments of the synaptonemal complex, is located along the 
synapsed lateral elements in the wild-type oocyte from the early-zygotene 
stage (top left and middle panels) until the late-zygotene stage (top right 
panel), when almost all the lateral elements are synapsed. However, the 
Stag3−/− oocytes that are arrested at the leptotene-like stage (bottom panels) 
do not show SYCP1 staining or synapsis; the top and bottom middle and 
right panels also show DAPI staining of DNA in blue.
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esting to investigate whether women carrying 
STAG3 mutations resulting in premature ovarian 
failure have an increased risk of germ-cell tumors.
Our results implicate STAG3 mutation in pre-
mature ovarian failure and the meiosis-specific 
cohesin complexes in enabling fertility. Further 
studies are required to understand the associa-
tion between genetic variants in STAG3, human 
infertility, and ovarian tumorigenesis. We pro-
pose that mutations affecting other meiosis-spe-
cific subunits of the cohesin complex could lead 
to similar functional defects and explain ovarian 
failure in women with premature ovarian failure.
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